Search for a clinical trial
Other search option(s)
2 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
SPAIN
Madrid
MADRID
A Phase 1/2 First-in-human, 2-part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (Part 1: Open-label) and Repeat Doses (Part 2: Randomized, Double-blind, Placebo-controlled) of UX053 in Patients with GSD III - ES
Hospital Universitario 12 de Octubre
UNITED KINGDOM
Greater Manchester
MANCHESTER